Joints Affected by Hyperuricemia
The first metatarsophalangeal (MTP) joint is the most commonly affected joint in hyperuricemia-related gout, followed by the ankle and knee joints. 1
Most Commonly Affected Joints
Based on the most recent EULAR guidelines, the typical pattern of joint involvement includes:
Primary Sites
- First metatarsophalangeal joint (great toe) - This is the classic presentation known as "podagra" and represents the most frequent site of monosodium urate (MSU) crystal deposition 1
- Ankle joint - Second most common lower extremity site 1
- Knee joint - Frequently involved, particularly the femoral condyle cartilage 1, 2, 3
Secondary Sites
Research evidence demonstrates additional common sites of crystal deposition 2:
- Other metatarsophalangeal joints of the foot (67.4% of patients with intra-articular crystals)
- Knee joints (23.2%)
- Ankle joints (20.9%)
Clinical Presentation Pattern
Monoarticular involvement of a foot or ankle joint, especially the first MTP joint, is highly suggestive of gout and represents one of the key diagnostic features when synovial fluid analysis is not feasible 1. The 2018 EULAR guidelines specifically emphasize that this presentation pattern, combined with rapid onset of severe pain and swelling reaching maximum intensity within 24 hours, strongly supports a clinical diagnosis 1.
Tendon Involvement
Beyond joints, hyperuricemia also causes crystal deposition in tendons 2:
- Quadriceps tendon (43.2% of patients with tendon crystals)
- Achilles tendon (35.1%)
- Patellar tendon (32.4%)
- Triceps brachii tendon (13.5%)
Atypical Presentations
While the first MTP joint is classic, atypical presentations affecting other joints are not rare 1. This includes potential involvement of the proximal interphalangeal joints of toes 4 and even spinal involvement in some cases 5. When gout presents in unusual locations, imaging (particularly ultrasound or dual-energy CT) should be used to search for MSU crystal deposition 1.
Asymptomatic Hyperuricemia
In asymptomatic hyperuricemia (elevated uric acid without symptoms), subclinical urate deposition can occur but at significantly lower frequency and volume compared to symptomatic gout. When present, these deposits preferentially affect the articular cartilage of the knee and first MTP joint 6, 3.